U-Blot® Research Grade BremzalerbartCat. No. WA2548$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade BremzalerbartCat. No. WA2548
U-Blot® Research Grade brelovitugCat. No. WA2547
U-Blot® Research Grade BrazikumabCat. No. WA2546
U-Blot® Research Grade BotensilimabCat. No. WA2545
U-Blot® Research Grade BoserolimabCat. No. WA2544
U-Blot® Research Grade BosakitugCat. No. WA2543
U-Blot® Research Grade bocunebartCat. No. WA2542
U-Blot® Research Grade BococizumabCat. No. WA2541
U-Blot® Research Grade BMS-962476Cat. No. WA2540
U-Blot® Research Grade BMS-936559/MDX-1105Cat. No. WA2539
U-Blot® Research Grade BlosozumabCat. No. WA2538
U-Blot® Research Grade BlontuvetmabCat. No. WA2537